Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.75
-2.71 (-15.52%)
At close: Dec 5, 2025, 4:00 PM EST
14.79
+0.04 (0.27%)
After-hours: Dec 5, 2025, 7:58 PM EST
Adaptive Biotechnologies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -79.49 | -159.49 | -225.25 | -200.19 | -207.28 | -146.23 | |
| Depreciation & Amortization | 18.09 | 19.26 | 22.23 | 20.92 | 13.95 | 8.47 | |
| Asset Writedown & Restructuring Costs | - | 7.21 | 25.43 | - | - | - | |
| Loss (Gain) From Sale of Investments | -3.68 | -8.21 | -9.18 | 0.74 | 7.23 | 0.77 | |
| Stock-Based Compensation | 51.6 | 53.61 | 62.91 | 55.48 | 43.25 | 24.76 | |
| Other Operating Activities | 5.22 | 9.87 | 13.73 | 10.65 | 6.93 | 3.34 | |
| Change in Accounts Receivable | -4 | -3.74 | 2.03 | -22.65 | -7.36 | 2.61 | |
| Change in Inventory | 2.39 | 5.37 | -2.84 | 0.82 | -5.2 | -4.99 | |
| Change in Accounts Payable | 3.76 | 0.67 | -5.41 | 7.11 | 3.94 | 7.5 | |
| Change in Unearned Revenue | -42.09 | -10.48 | -29.29 | -56.5 | -57.73 | -43.39 | |
| Change in Other Net Operating Assets | -12.33 | -9.28 | -10.68 | -0.33 | 9.53 | -2.52 | |
| Operating Cash Flow | -60.53 | -95.21 | -156.32 | -183.95 | -192.73 | -149.68 | |
| Capital Expenditures | -2.4 | -3.66 | -10.7 | -16.35 | -61.75 | -18.8 | |
| Investment in Securities | 70.72 | 81.46 | 140.34 | 19.25 | 242.96 | -98.24 | |
| Investing Cash Flow | 68.32 | 77.79 | 129.65 | 2.91 | 181.21 | -117.04 | |
| Issuance of Common Stock | 8.87 | 0.24 | 2.25 | 7.89 | 26.72 | 293.91 | |
| Other Financing Activities | - | - | - | 124.38 | 0.43 | -0.32 | |
| Financing Cash Flow | 8.87 | 0.24 | 2.25 | 132.27 | 27.15 | 293.59 | |
| Net Cash Flow | 16.66 | -17.18 | -24.43 | -48.78 | 15.63 | 26.86 | |
| Free Cash Flow | -62.94 | -98.88 | -167.02 | -200.29 | -254.47 | -168.49 | |
| Free Cash Flow Margin | -24.90% | -55.25% | -98.09% | -108.09% | -164.87% | -171.26% | |
| Free Cash Flow Per Share | -0.42 | -0.67 | -1.16 | -1.41 | -1.81 | -1.28 | |
| Cash Interest Paid | 10.26 | 8.86 | 8.99 | 0.49 | - | - | |
| Levered Free Cash Flow | 1.29 | -24.48 | -81.95 | -90.17 | -139.1 | -60.55 | |
| Unlevered Free Cash Flow | 8.65 | -17.24 | -73.33 | -87.53 | -139.1 | -60.55 | |
| Change in Working Capital | -52.26 | -17.45 | -46.18 | -71.55 | -56.82 | -40.8 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.